FMT
TNDM icon

First Mercantile Trust’s Tandem Diabetes Care TNDM Stock Holding History

First Mercantile Trust’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$312K Sell
2,607
-222
-8% -$24.5K 0.04% 263
2021
Q2 		$276K Sell
2,829
-103
-4% -$9.19K 0.03% 311
2021
Q1 		$258K Sell
2,932
-923
-24% -$85.8K 0.03% 341
2020
Q4 		$369K Sell
3,855
-449
-10% -$46.3K 0.04% 247
2020
Q3 		$451K Sell
4,304
-944
-18% -$99.2K 0.05% 193
2020
Q2 		$519K Sell
5,248
-5,303
-50% -$423K 0.07% 166
2020
Q1 		$679K Sell
10,551
-440
-4% -$30.8K 0.1% 113
2019
Q4 		$655K Sell
10,991
-3,430
-24% -$212K 0.08% 171
2019
Q3 		$851K Sell
14,421
-3,576
-20% -$228K 0.09% 140
2019
Q2 		$1.16M Sell
17,997
-6,354
-26% -$410K 0.12% 91
2019
Q1 		$1.55M Sell
24,351
-5,397
-18% -$283K 0.36% 54
2018
Q4 		$1.13M Buy
29,748
+4,780
+19% +$169K 0.27% 80
2018
Q3 		$1.07M Sell
24,968
-16,147
-39% -$564K 0.21% 109
2018
Q2 		$905K Sell
41,115
-3,751
-8% -$46.1K 0.18% 127
2018
Q1 		$223K Buy
44,866
+40,969
+1,051% +$132K 0.05% 463
2017
Q4 		$9K Sell
3,897
-1,939
-33% -$6.09K ﹤0.01% 804
2017
Q3 		$43K Sell
5,836
-97
-2% -$614 0.01% 775
2017
Q2 		$47K Hold
5,933
– – 0.01% 790
2017
Q1 		$71K Buy
5,933
+4,501
+314% +$98.4K 0.01% 774
2016
Q4 		$31K Sell
1,432
-172
-11% -$6.62K ﹤0.01% 810
2016
Q3 		$123K Sell
1,604
-178
-10% -$13K 0.02% 691
2016
Q2 		$134K Sell
1,782
-180
-9% -$14.5K 0.02% 672
2016
Q1 		$171K Sell
1,962
-194
-9% -$17K 0.02% 613
2015
Q4 		$255K Sell
2,156
-1,039
-33% -$103K 0.03% 608
2015
Q3 		$282K Buy
3,195
+226
+8% +$26.3K 0.03% 594
2015
Q2 		$322K Buy
2,969
+160
+6% +$19.9K 0.03% 617
2015
Q1 		$355K Buy
+2,809
New +$365K 0.03% 597

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

First Mercantile Trust's TNDM Position: Q3 2021 in Review

First Mercantile Trust reduced its Tandem Diabetes Care (TNDM) stake by 7.8% in Q3 2021, selling an estimated $24.5K and leaving 2,607 shares worth $312K. The position accounts for 0.04% of the portfolio, ranked #263.

First Mercantile Trust first reported a position in TNDM in Q1 2015 and has held it in 27 quarters since. The position peaked at $1.55M in Q1 2019. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

  • First Mercantile Trust held 2,607 shares of Tandem Diabetes Care worth $312K as of Q3 2021.
  • First Mercantile Trust sold 222 Tandem Diabetes Care shares in Q3 2021, an estimated $24.5K.
  • Tandem Diabetes Care made up 0.04% of First Mercantile Trust's portfolio in Q3 2021, its #263 holding.
  • First Mercantile Trust first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 27 quarters since.
  • First Mercantile Trust's Tandem Diabetes Care position peaked at $1.55M in Q1 2019.
  • 337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.